Key result
Vernonia amygdalina extract reduces TGF, cytochrome c, and apoptosis in doxorubicin-induced rat cardiotoxicity.
Why the study?
Doxorubicin-induced cardiotoxicity remains unpreventable due to an incomplete understanding of its underlying mechanisms.
Does Vernonia amygdalina ethanol extract prevent doxorubicin-induced cardiotoxicity in rats?
Does Vernonia amygdalina ethanol extract prevent doxorubicin-induced cardiotoxicity in rats?
p-value: p=<0.001
Vernonia amygdalina ethanol extract demonstrates dose-dependent cardioprotective effects against doxorubicin-induced cardiotoxicity in a rat model by reducing apoptosis and oxidative stress markers.
Should not change doxorubicin cardiotoxicity management; hypothesis-generating for Vernonia amygdalina in animal models.
Doxorubicin (DOX) has been extensively utilized in cancer treatment. However, DOX administration has adverse effects, such as cardiac injury. This study intends to analyze the expression of TGF, cytochrome c, and apoptosis on the cardiac histology of rats induced with doxorubicin, since the prevalence of cardiotoxicity remains an unpreventable problem due to a lack of understanding of the mechanism underlying the cardiotoxicity result. Vernonia amygdalina ethanol extract (VAEE) was produced by soaking dried Vernonia amygdalina leaves in ethanol. Rats were randomly divided into seven groups: K- (only given doxorubicin 15 mg/kgbw), KN (water saline), P100, P200, P400, P4600, and P800 (DOX 15 mg/kgbw + 100, 200, 400, 600, and 800 mg/kgbw extract); at the end of the study, rats were scarified, and blood was taken directly from the heart; the heart was then removed. TGF, cytochrome c, and apoptosis were stained using immunohistochemistry, whereas SOD, MDA, and GR concentration were evaluated using an ELISA kit. In conclusion, ethanol extract might protect the cardiotoxicity produced by doxorubicin by significantly reducing the expression of TGF, cytochrome c, and apoptosis in P600 and P800 compared to untreated control K- (p < 0.001). These findings suggest that Vernonia amygdalina may protect cardiac rats by reducing the apoptosis, TGF, and cytochrome c expression while not producing the doxorubicinol as doxorubicin metabolite. In the future, Vernonia amygdalina could be used as herbal preventive therapy for patient administered doxorubicin to reduce the incidence of cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Syahputra et al. (2023) studied Doxorubicin-induced cardiotoxicity. Vernonia amygdalina ethanol extract vs. Doxorubicin only and water saline was evaluated on Expression of TGF, cytochrome c, and apoptosis (p=<0.001). Vernonia amygdalina ethanol extract (600 and 800 mg/kgbw) significantly reduced the expression of TGF, cytochrome c, and apoptosis in doxorubicin-induced cardiotoxicity in rats (p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: